Tandem Diabetes Care Inc

TNDM: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
@qLOCK|J$%LOCK|@J!@zR<

Tandem Diabetes Earnings: Despite Solid First-Quarter Results, We Expect Growth to Decelerate

Tandem racked up 22% quarterly revenue growth, driven by strong consumables demand outside the US and favorable average selling price thanks to Mobi.

Sponsor Center